Scinai Immunotherapeutics Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2022 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Scinai Immunotherapeutics Ltd. annual/quarterly Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2022 to Q2 2023.
  • Scinai Immunotherapeutics Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 1.35B shares, a 81% increase year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.56B shares, a 107% increase from 2022.
  • Scinai Immunotherapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 754M shares, a 33.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 1.35B +605M +81% Apr 1, 2023 Jun 30, 2023 6-K/A 2023-08-18
Q1 2023 1.3B +551M +73.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q2 2022 747M Apr 1, 2022 Jun 30, 2022 6-K/A 2023-08-18
Q1 2022 745M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.